Pyxis Oncology: Readouts Ahead, Although Cash Might Dwindle (Rating Downgrade)
Source: SeekingAlpha
2025-09-12 11:44:56 ET
...
Read the full article on Seeking Alpha
For further details see:
Pyxis Oncology: Readouts Ahead, Although Cash Might Dwindle (Rating Downgrade)
Immutep Limited
NASDAQ: IMMP
IMMP Trading
0.37% G/L:
$2.70 Last:
58,447 Volume:
$2.74 Open:
IMMP Latest News
February 06, 2026 08:00:00 am
Immutep Achieves 50% Enrolment in Global TACTI-004 (KEYNOTE-F91) Phase III Trial in 1L NSCLC
IMMP Stock Data
$413,609,616
143,291,445
N/A
6
N/A
Biotechnology & Life Sciences
Healthcare
AU
Sydney
